Peter Libby, MD, is a cardiovascular specialist at Brigham and Women’s Hospital in Boston, Massachusetts, and holds the Mallinckrodt Professorship of Medicine at Harvard Medical School. His areas of clinical expertiseinclude general and preventive cardiology. His current major research focus is the role of inflammation in vascular diseases such as atherosclerosis. Dr. Libby has a particular devotion to translate his basic laboratory studies to pilot and then large-scale clinical cardiovascular outcome trials. He instigated and helped to lead the large-scale CANTOS trial that provided clinical validation of the role of inflammation in atherosclerosis.
Dr. Libby has received numerous awards for his research accomplishments, including the Gold Medal of the European Society of Cardiology in 2011, the Anitschkow Prize in Atherosclerosis Research of the EuropeanAtherosclerosis Society in 2013. He was the laureate of the Ernst Jung Gold Medal for Medicine for 2016. In 2019 he was honored with the Research Achievement Award of the American Heart Association and was the recipient of the 2020 Paul Dudley White Award of the American Heart Association.
An author and lecturer on cardiovascular medicine and atherosclerosis, Dr. Libby has published extensively in top ranked medical journals. He is the Editor-in Chief for the 12th edition of Braunwald’s Heart Disease. His h index is 236, 124 since 2016, with over 250,000 citations.
Dr. Libby earned his medical degree at the University of California, San Diego, and completed his training in internal medicine and cardiology at the Peter Bent Brigham Hospital (now Brigham and Women’s Hospital). He also holds an honorary MA degree from Harvard University, and Doctorat honoris causa from the Université de Lille, France , Université Laval in Québec, Canada, and Doctor Medicinæ Honoris Causa degree from Goethe University, Frankfurt am Main, Germany.